Navigation Links
Telome Health Co-founder and Nobel Laureate Elizabeth Blackburn Awarded Innovator of the Year
Date:2/23/2012

MENLO PARK, Calif., Feb. 23, 2012 /PRNewswire/ -- Telome Health, Inc.™, a privately held biotechnology company focused on the role of telomere biology in human health, has announced that co-founder and Nobel Laureate Elizabeth Blackburn has been awarded Innovator of the Year by Silicon Valley Business Journal.

"I am very pleased and honored to receive this award, especially coming from the heart of innovation, Silicon Valley, and to acknowledge the efforts of my amazing colleagues," said Dr. Blackburn.

Dr. Blackburn is an internationally recognized thought leader and expert on the biology of telomeres. She was awarded the 2009 Nobel Prize in Medicine and Physiology along with Drs. Carol Greider and Jack Szostak for her work in this field. She co-founded Telome Health in 2010 with colleagues Calvin Harley, Elissa Epel and Jue Lin who also recognized experts in the field of telomere biology. Dr. Blackburn is Morris Herzstein Professor of Biology and Physiology at the University of California at San Francisco. She also serves on the Board and is a Scientific Advisory for Telome Health.

"We are thrilled that Dr. Blackburn has been awarded the Innovator of The Year by The Silicon Valley and San Jose Business Journal," noted Daniel Hunt, CEO of Telome Health. "This is just one of the many notable and prestigious awards that she has received for her significant contributions to the field of telomere biology. We are proud to work with Elizabeth to develop a diagnostic test that will further empower individuals and physicians to manage disease risk using a more proactive, personalized approach."

Telome Health, Inc. is developing a proprietary assay that measures telomere length called the TeloTest™ that it anticipates launching in 2012. Telomeres are repetitive DNA sequences at the ends of human chromosomes that protect them from unraveling similar to the plastic tips (aglets) located on the ends of shoelaces. Research supports that as telomeres get shorter, the chromosome becomes less stable. If this shortening occurs faster than is observed in a normal or healthy population, it may be an indication of stress or other co-morbid factors that have not yet been detected by other tests or actual symptoms.  

The TeloTest assay utilizes quantitative polymerase chain assay, also called qPCR, and is the most clinically validated technology used to determine telomere length. "The body of scientific and clinical evidence using qPCR is enormous," said Blackburn. "It is really the technology for which all others should be compared since such studies using this technology conclusively support that negative changes in telomere length is directly associated to aging and disease risk."

Envisaged as being taken annually, the test serves as a "check engine" light that may provide an early warning to individuals and their physicians that further medical assessment or changes in lifestyle habits are warranted.

About Telome Health, Inc.

Telome Health, Inc. is a privately held biotechnology company that is focused on developing proprietary telomere based technologies to diagnose, prevent and treat human disease. Its first product, the TeloTest is anticipated to launch in 2012. The company was co-founded by Elizabeth Blackburn who was awarded the Nobel Prize in Medicine for her scientific contributions in the field of telomere biology and Drs. Calvin Harley, Elissa Epel and Jue Li who are internationally recognized experts in this field. The company is located in Menlo Park, CA.

Contact:

Patricia Sinatra
VP of Corporate Development and Strategy
Telome Health, Inc.
650.289.0289
http://www.telomehealth.com/media/index.html


'/>"/>
SOURCE Telome Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Life Length Telomere Test Available Nationwide
2. SpectraCells Telomere Testing Goes Mainstream
3. Neurocrine Biosciences to Present at the Citi 2012 Global Health Care Conference
4. Life Technologies to Present at Barclays Capital Global Healthcare Conference
5. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
6. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
7. Nabsys to Present DNA Sequence Data from Solid-State Nanodetectors at the Annual Advances in Genome Biology and Technology (AGBT) Meeting and the EMBL Omics and Personalized Health Conference
8. Regeneron Announces Presentation at the Leerink Swann 2012 Global Healthcare Conference
9. Amgen to Present at the Leerink Swann Global Healthcare Conference
10. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
11. Genomic Health Announces Year-End 2011 Financial Results, Provides 2012 Financial Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... Summit for ... to support the development of a patient-specific stem cell therapy for the treatment of ... lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, CA. ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... support for Connecticut's innovative, growing companies, today announced the launch of VentureClash ... technology (fintech) companies. , “VentureClash looks to attract the best early-stage ...
(Date:4/27/2016)... ... April 27, 2016 , ... ... technology at the Spring 2016 Marijuana Business Conference and Expo. Shimadzu’s high-performance instruments ... heavy metals, and more. Expo attendees can stop by booth 1021 to learn ...
(Date:4/27/2016)... British Virgin Islands (PRWEB) , ... April 27, ... ... Holding Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton ... he was an Executive Director and one of the founding commercial leaders responsible ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):